Economic Atlas
WORKSPACE
OverviewScreenerWatchlistChatAccount
EXPLORE
CompaniesPlacesPlace screenerMethodology
Terms·Privacy
Economic Atlas
HomeScreenerChatCompanies
Economic Atlas
WORKSPACE
OverviewScreenerWatchlistChatAccount
EXPLORE
CompaniesPlacesPlace screenerMethodology
Terms·Privacy
Economic Atlas
Companies/Prime Medicine, Inc.
Company profile

Prime Medicine, Inc.

NASDAQ: PRME · Healthcare · Biotechnology
PublicHQ Cambridge, MA · MiddlesexCIK 0001894562Reports USD
#708 of 1,394 Healthcare companies by revenuetop-quartile growth
EA Score
37D
FH 29DQ 45GM —SS 54
v0.1 · 55/100 weight · provisional
↑ revenue growth (YoY), market scale · ↓ listing tenure, operating margin
Methodology →
Revenue TTM
$4.0M
Rev growth YoY (TTM)
+4.9%
Net income (FY)
-$201.1M
Employees
214
Market cap
$699.0M
OverviewFinancialsSegmentsFilingsESGPeople & Places

Financials — latest annual

SEC EDGAR · USD-normalized
ConceptUSDNativeFY
Revenue$4.6M$4.6M2025
Net income-$201.1M-$201.1M2025
Operating income-$208.3M-$208.3M2025
Total assets$342.7M$342.7M2025
Liabilities$221.9M$221.9M2025
Equity$120.9M$120.9M2025

Revenue trend

FY2022 – FY2025 · USD
$5.2M
FY22
$0
FY22
$0
FY22
$0
FY24
$3.0M
FY24
$4.6M
FY25

Revenue by segment

Filed disclosures · FY2025
By product
Reportable100%
By geography

Not disclosed.

The read

Prime Medicine, Inc. booked $4.6M in FY2025 revenue, growing 55% year over year — faster than most Healthcare companies we track, at a -4342.4% net margin.

Peers · Healthcare
Jade Biosciences, Inc.——Tactile Systems Technology, Inc.82B+Bioventus Inc.66BREGENXBIO Inc.54D
Neighbors
Middlesex →
GE Vernova Inc.$38.1B63CThermo Fisher Scientific Inc.$44.6B86AAnalog Devices, Inc.$11.0B87AThe TJX Companies, Inc.$60.4B85ABoston Scientific Corporation$20.1B88AAlnylam Pharmaceuticals, Inc.$3.7B79B+
Key facts
CEOAllan Reine
SectorHealthcare
IndustryBiotechnology
HeadquartersCambridge, MA
ExchangeNASDAQ: PRME
Employees214
IPO date2022-10-20
Latest filings
8-K2026-07-088-K2026-06-0810-Q2026-05-078-K2026-05-07DEF 14A2026-04-238-K2026-04-168-K2026-03-0310-K2026-03-03
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.
HomeScreenerChatCompanies